Epitalon Protocol

Evidence Level: Investigational / Theoretical

Primarily preclinical or very limited human data — mechanism-based reasoning more than a demonstrated clinical effect. Treat as investigational.

Human evidence: Human literature is concentrated in older Russian studies; modern independent replication is limited.

Animal evidence: Rodent lifespan and pineal-signaling studies from the original research program.

Introduction & Mechanism of Action

Experimental peptide bioregulator investigated in aging-related cellular pathways.

Synthetic tetrapeptide studied primarily in older Russian research for potential telomerase-activation and circadian/pineal-signaling effects; modern independent replication of the original studies is limited.

Receptors/targets: No confirmed classical receptor — proposed telomerase and pineal-signaling pathway modulation

Areas of Research Interest

• Aging biology
• Circadian and endocrine research
• Cellular longevity pathways

Benefits Reported in Research

• Cellular-aging research
• Circadian and sleep-pattern studies
• Endocrine-signaling research

Reported Research Dosing Range

The figures below are cited from published research literature and protocol references — they describe what has been studied, not a personal prescription or instruction.

Reported range: 5–10 mg

Reported frequency: 1× daily, subcutaneous

Reported cycle duration: 10–20 days

Escalation & maintenance: A dedicated weekly escalation and maintenance schedule specific to this peptide has not yet been published here — follow the dose range and frequency above, titrating conservatively from the low end, and consult a physician before adjusting.

Research Reference Data

Published research on Epitalon reports administration at 5–10 mg via subcutaneous route. The table below cites that published research — it is not an individualized instruction.

Reconstitution Reference

Published research protocols reconstitute a 10 mg vial with 2 mL bacteriostatic water, yielding a concentration of 5.00 mg/mL. This is cited reference information, not a personalized preparation instruction — use the general research calculator below for your own reference computation.

Research Protocol Timeline

A reference summary of how this compound is described across published research — formulation, reported administration, and reported cycle length.

Dilution Guide

Reconstitute with 2 mL bacteriostatic water

Bacteriostatic Water (BAC Water) is the only recommended diluent. Do not dilute with sterile water, normal saline, lidocaine, or any other solution unless explicitly specified by the manufacturer.

Handling Guide

General laboratory handling practice cited for reference — not a personalized instruction. Any human use should follow the guidance of a licensed physician.

Wash hands and clean the injection site with an alcohol swab. Pinch a fold of skin and insert the needle at a 45–90° angle for standard subcutaneous injection (abdomen, thigh, or upper arm). Inject slowly, withdraw, and apply gentle pressure. Rotate injection sites to reduce irritation, and dispose of needles in an approved sharps container.

Storage

Store lyophilized (powder) vials in a freezer at -20°C, protected from light. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within the timeframe recommended in your supplier documentation — typically 2–4 weeks.

Monitoring

Monitor for injection-site reactions and the side effects listed above. Stop use and consult a physician if severe or persistent reactions occur. This is a general monitoring guideline, not a personalized medical monitoring plan.

Side Effects

• Injection-site irritation (most commonly reported)

Contraindications

• Active or history of malignancy (theoretical concern given proposed telomerase mechanism)
• Pregnancy

Drug interactions

• Not characterized — no controlled human drug-interaction studies exist

Safety

• No meaningful modern human safety database
• Telomerase-activation mechanism raises a theoretical (unproven) cancer-risk research question given telomerase's role in some cancer biology

Historical programs require modern independent replication. FDA reports insufficient safety information for proposed compounded use.

Expected Results & Comparison

Epitalon is the catalog peptide most specifically associated with circadian-rhythm and telomerase-pathway longevity research, distinct from NAD+'s metabolic-coenzyme mechanism and SS-31's mitochondrial-membrane mechanism — historical programs require modern independent replication before the telomerase-activation claim can be considered established.

References

Continue